Baird's research team still looks for more signs of a revenue uptick before issuing an upgrade...

|By:, SA News Editor

Baird's research team still looks for more signs of a revenue uptick before issuing an upgrade on Dendreon (DNDN +2.7%), but it sees management starting a credible turnaround path and suggests some exposure given the negative sentiment and low valuation. Near-term Provenge problems seem fixable, the firm says, and cost-efficiency measures should lower cost of goods sold.